CJC-1295 5mg (No DAC) + Ipamorelin 5mg Total 10mg

Advanced Growth Hormone Secretagogue Research Stack

CJC-1295 (No DAC) combined with Ipamorelin is one of the most widely studied dual-peptide combinations in growth hormone and recovery-focused research.

Researchers investigating body composition, recovery pathways, sleep quality, tissue repair, and healthy ageing are particularly interested in this peptide stack because of its apparent ability to stimulate natural pulsatile growth hormone (GH) release while maintaining a more physiologically regulated signalling profile.

Unlike exogenous growth hormone administration, this combination is studied for its interaction with the body’s own endogenous GH signalling systems.

Bio Hackers Peptides supplies high-purity CJC-1295 (No DAC) and Ipamorelin research compounds within Australia with fast domestic dispatch and batch-verified purity testing.

Supplied as lyophilised (freeze-dried) powder, these compounds are intended strictly for laboratory and in-vitro research purposes only.

Why Researchers Combine CJC-1295 (No DAC) & Ipamorelin

Researchers are particularly interested in this stack because the two peptides target complementary pathways involved in growth hormone regulation.

CJC-1295 (No DAC)

CJC-1295 (No DAC) is a Growth Hormone-Releasing Hormone (GHRH) analogue.

Researchers study it for its ability to stimulate the pituitary gland through GHRH receptor activation, encouraging natural growth hormone signalling.

Unlike the DAC version, the “No DAC” variation has a shorter active duration, making it more suitable for studies involving pulsatile GH release patterns rather than prolonged elevation.

This shorter-acting profile is often preferred in physiological rhythm research.

Ipamorelin

Ipamorelin is a selective Growth Hormone Secretagogue (GHS) and ghrelin receptor agonist.

Researchers investigate Ipamorelin because of its apparent ability to amplify natural GH pulses while producing comparatively lower activity involving:

• Cortisol pathways

• Prolactin signalling

• Non-selective endocrine stimulation

Its more targeted signalling profile has led to it being commonly described in research settings as a “cleaner” GH secretagogue.

How the Stack Is Commonly Studied

Researchers investigate whether combining both peptides may produce synergistic signalling effects across multiple pathways related to:

• Growth hormone pulsatility

• Recovery signalling

• Sleep regulation

• Tissue repair

• Body composition

• Cellular regeneration

• Metabolic adaptation

The combination is designed to mimic more natural physiological growth hormone rhythms rather than creating constant elevated GH exposure.

Body Composition & Metabolic Research

One of the major areas of research interest involves body-composition pathways.

Experimental models have investigated whether this peptide combination may influence:

• Fat metabolism

• Visceral-fat pathways

• Lean-mass support

• Nutrient partitioning

• Metabolic efficiency

• Recovery-related anabolic signalling

Researchers continue studying how endogenous GH stimulation may interact with body-composition regulation.

Recovery & Tissue-Repair Research

The stack is also commonly studied in models involving:

• Muscle recovery

• Connective tissue repair

• Joint support pathways

• Recovery adaptation

• Exercise-related recovery signalling

• Tissue-regeneration mechanisms

Researchers are particularly interested in the role growth hormone signalling may play in repair-related biological processes.

Sleep & Recovery Quality Research

Because growth hormone secretion is closely linked with deep sleep cycles, researchers additionally investigate this combination for its interaction with:

• Sleep quality

• Restorative sleep pathways

• Recovery-related neuroendocrine signalling

• Circadian hormone rhythms

• Night-time GH pulsatility

Experimental observations frequently explore whether improved sleep architecture may contribute to broader recovery-related effects.

Why Researchers Prefer “No DAC”

The “No DAC” variation of CJC-1295 is often preferred in physiological research because of its shorter half-life.

Researchers investigate this format for its ability to produce:

• Controlled GH pulses

• More natural endocrine rhythms

• Reduced continuous receptor stimulation

• Flexible protocol timing

This differs from longer-acting DAC formulations designed to maintain elevated GH signalling for extended periods.

Research Observations & Safety Context

Experimental observations involving this peptide stack have generally reported mild effects within research settings.

Reported observations in experimental models have included:

• Temporary injection-site irritation

• Mild swelling or redness

• Water-retention-related signalling

• Transient appetite changes

Researchers continue investigating long-term endocrine interactions and recovery-related pathways.

Regulatory & Research Status

These compounds remain investigational in many jurisdictions and are commonly supplied for:

• Laboratory research

• Experimental endocrine studies

• Compounding-related research applications

Neither peptide has been broadly approved by agencies including:

• U.S. Food and Drug Administration

• Therapeutic Goods Administration

for general therapeutic use.

Product Information

All products are sourced, tested, and dispatched entirely within Australia with fast domestic shipping and batch-specific Certificate of Analysis (CoA) verification available through the CoA Library or by scanning the QR code supplied with each product.

⚠ For in-vitro research and laboratory use only. Not for human consumption.

⚠ By purchasing, you confirm you are a qualified researcher and will use this compound in accordance with all applicable laws and regulations.